Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 17

1.

Randomized Controlled Trial to Compare Immunogenicity of Standard-Dose Intramuscular Versus Intradermal Trivalent Inactivated Influenza Vaccine in HIV-Infected Men Who Have Sex With Men in Bangkok, Thailand.

Garg S, Thongcharoen P, Praphasiri P, Chitwarakorn A, Sathirapanya P, Fernandez S, Rungrojcharoenkit K, Chonwattana W, Mock PA, Sukwicha W, Katz JM, Widdowson MA, Curlin ME, Gibbons RV, Holtz TH, Dawood FS, Olsen SJ.

Clin Infect Dis. 2016 Feb 1;62(3):383-91. doi: 10.1093/cid/civ884. Epub 2015 Oct 20.

2.

Technical guidelines for the application of seasonal influenza vaccine in China (2014-2015).

Feng L, Yang P, Zhang T, Yang J, Fu C, Qin Y, Zhang Y, Ma C, Liu Z, Wang Q, Zhao G, Yu H.

Hum Vaccin Immunother. 2015;11(8):2077-101. doi: 10.1080/21645515.2015.1027470.

PMID:
26042462
3.

Vaccination in HIV-infected adults.

Crum-Cianflone NF, Wallace MR.

AIDS Patient Care STDS. 2014 Aug;28(8):397-410. doi: 10.1089/apc.2014.0121. Epub 2014 Jul 16. Review.

4.

Comparing the efficacy of efavirenz and boosted lopinavir using viremia copy-years.

Lima VD, Sierra-Madero J, Wu Z, Singer J, Wood E, Hull MW, Richard Harrigan P, Montaner JS.

J Int AIDS Soc. 2014 May 6;17:18617. doi: 10.7448/IAS.17.1.18617. eCollection 2014.

5.

Decreased serologic response in vaccinated military recruits during 2011 correspond to genetic drift in concurrent circulating pandemic A/H1N1 viruses.

Faix DJ, Hawksworth AW, Myers CA, Hansen CJ, Ortiguerra RG, Halpin R, Wentworth D, Pacha LA, Schwartz EG, Garcia SM, Eick-Cost AA, Clagett CD, Khurana S, Golding H, Blair PJ.

PLoS One. 2012;7(4):e34581. doi: 10.1371/journal.pone.0034581. Epub 2012 Apr 13.

6.

Cellular and humoral immune responses to pandemic influenza vaccine in healthy and in highly active antiretroviral therapy-treated HIV patients.

Agrati C, Gioia C, Castilletti C, Lapa D, Berno G, Puro V, Carletti F, Cimini E, Nisii C, Castellino F, Martini F, Capobianchi MR.

AIDS Res Hum Retroviruses. 2012 Dec;28(12):1606-16. doi: 10.1089/AID.2011.0371. Epub 2012 May 8.

7.

Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective.

Beck CR, McKenzie BC, Hashim AB, Harris RC, Zanuzdana A, Agboado G, Orton E, Béchard-Evans L, Morgan G, Stevenson C, Weston R, Mukaigawara M, Enstone J, Augustine G, Butt M, Kim S, Puleston R, Dabke G, Howard R, O'Boyle J, O'Brien M, Ahyow L, Denness H, Farmer S, Figureroa J, Fisher P, Greaves F, Haroon M, Haroon S, Hird C, Isba R, Ishola DA, Kerac M, Parish V, Roberts J, Rosser J, Theaker S, Wallace D, Wigglesworth N, Lingard L, Vinogradova Y, Horiuchi H, Peñalver J, Nguyen-Van-Tam JS.

PLoS One. 2011;6(12):e29249. doi: 10.1371/journal.pone.0029249. Epub 2011 Dec 22. Review.

8.

Risk factors for hospitalized seasonal influenza in rural western Kenya.

Ope MO, Katz MA, Aura B, Gikunju S, Njenga MK, Ng'ang'a Z, Vulule J, Breiman RF, Feikin DR.

PLoS One. 2011;6(5):e20111. doi: 10.1371/journal.pone.0020111. Epub 2011 May 26.

9.

Durability of antibody responses after receipt of the monovalent 2009 pandemic influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adults.

Crum-Cianflone NF, Iverson E, Defang G, Blair PJ, Eberly LE, Maguire J, Ganesan A, Faix D, Duplessis C, Lalani T, Whitman T, Brandt C, Macalino G, Millar EV, Burgess T.

Vaccine. 2011 Apr 12;29(17):3183-91. doi: 10.1016/j.vaccine.2011.02.040. Epub 2011 Mar 1.

10.

Immunogenicity of a monovalent 2009 influenza A (H1N1) vaccine in an immunocompromised population: a prospective study comparing HIV-infected adults with HIV-uninfected adults.

Crum-Cianflone NF, Eberly LE, Duplessis C, Maguire J, Ganesan A, Faix D, Defang G, Bai Y, Iverson E, Lalani T, Whitman T, Blair PJ, Brandt C, Macalino G, Burgess T.

Clin Infect Dis. 2011 Jan 1;52(1):138-46. doi: 10.1093/cid/ciq019. Epub 2010 Dec 7.

11.

Predictors of reported influenza vaccination in HIV-infected women in the United States, 2006-2007 and 2007-2008 seasons.

Althoff KN, Anastos K, Nelson KE, Celentano DD, Sharp GB, Greenblatt RM, French AL, Diamond DJ, Holman S, Young M, Gange SJ.

Prev Med. 2010 May-Jun;50(5-6):223-9. doi: 10.1016/j.ypmed.2010.03.007. Epub 2010 Mar 18.

12.

Influenza vaccines: from surveillance through production to protection.

Tosh PK, Jacobson RM, Poland GA.

Mayo Clin Proc. 2010 Mar;85(3):257-73. doi: 10.4065/mcp.2009.0615. Epub 2010 Jan 29. Review.

13.

Pandemic influenza: implications for programs controlling for HIV infection, tuberculosis, and chronic viral hepatitis.

Heffelfinger JD, Patel P, Brooks JT, Calvet H, Daley CL, Dean HD, Edlin BR, Gensheimer KF, Jereb J, Kent CK, Lennox JL, Louie JK, Lynfield R, Peters PJ, Pinckney L, Spradling P, Voetsch AC, Fiore A.

Am J Public Health. 2009 Oct;99 Suppl 2:S333-9. doi: 10.2105/AJPH.2008.158170.

14.

Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses.

Kunisaki KM, Janoff EN.

Lancet Infect Dis. 2009 Aug;9(8):493-504. doi: 10.1016/S1473-3099(09)70175-6. Review.

15.

A review of influenza vaccine immunogenicity and efficacy in HIV-infected adults.

Cooper C, Hutton B, Fergusson D, Mills E, Klein MB, Boivin G, Halperin S.

Can J Infect Dis Med Microbiol. 2008 Nov;19(6):419-23.

16.

Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children.

Levin MJ, Song LY, Fenton T, Nachman S, Patterson J, Walker R, Kemble G, Allende M, Hultquist M, Yi T, Nowak B, Weinberg A.

Vaccine. 2008 Aug 5;26(33):4210-7. doi: 10.1016/j.vaccine.2008.05.054. Epub 2008 Jun 10.

17.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk